Overview: The White House Misses a Key Deadline
The Trump administration has confirmed it will not meet the federal deadline to nominate a permanent director for the Centers for Disease Control and Prevention (CDC). The Department of Health and Human Services (HHS) acknowledged the delay on Wednesday. As a result, the nation’s top public health agency continues to operate without a Senate-confirmed leader — a situation that has persisted for months.
HHS spokesperson Andrew Nixon confirmed the development in an official statement. He noted that Dr. Jay Bhattacharya would continue overseeing CDC operations. However, Bhattacharya will no longer carry the title of acting director under federal law.
What the Law Requires
The Federal Vacancies Act Deadline
Federal law strictly limits how long an acting officer can hold a position without Senate confirmation. Specifically, the Federal Vacancies Reform Act caps this period at 210 days. Wednesday marked that deadline for Bhattacharya’s time as acting CDC director.
Despite missing the deadline, Nixon clarified that the administration was not technically required to name a new candidate immediately. Instead, Bhattacharya “will continue to oversee the CDC by performing the delegable duties of the CDC director,” Nixon said. Consequently, he retains functional authority — just not the official title.
Bhattacharya’s Dual Role at CDC and NIH
Leading Two Agencies Simultaneously
Dr. Jay Bhattacharya currently serves as both the director of the National Institutes of Health (NIH) and the interim overseer of the CDC. These are two distinct federal agencies with separate missions and locations. Public health professionals have raised concerns about managing both simultaneously.
The CDC defended the arrangement in a statement. Officials said Bhattacharya has empowered NIH leadership to maintain routine operations. Furthermore, he will work closely with the CDC’s executive team to ensure continuity until a permanent director is confirmed.
Nixon also confirmed that Bhattacharya is actively participating in the candidate search. He is “evaluating candidates that can further the Trump administration’s objective of restoring the CDC to its original mission of fighting infectious disease.”
A History of CDC Leadership Turmoil
Revolving Door Since Trump’s Second Term
The CDC has faced significant leadership instability throughout Trump’s second term. Before the current situation, the White House withdrew its first CDC director nominee, Dr. Dave Weldon, a former Republican congressman from Florida. Weldon’s withdrawal came the night before his Senate confirmation hearing in March 2025. Reports indicated he lacked sufficient votes for confirmation.
Subsequently, Susan Monarez received Senate confirmation and became CDC director last July. However, the administration fired her just 29 days into her tenure. In congressional testimony, Monarez stated she was dismissed after refusing to approve changes to vaccine policy pushed by HHS Secretary Robert F. Kennedy Jr.
Therefore, the CDC has operated without a Senate-confirmed leader since August 2025 — nearly seven months. Several acting directors have cycled through the role, with Bhattacharya serving most recently since February 18.
New Confirmation Requirements Add Complexity
Before Trump’s second term, presidents simply appointed their own CDC directors without needing Senate approval. That changed with the CDC Leadership Accountability Act of 2023. Designed to strengthen agency oversight following pandemic-era missteps, this law now requires Senate confirmation for the CDC director role. As a result, the White House must find a nominee capable of winning bipartisan support.
Who Could Be the Next CDC Director?
Short List Emerging
While the White House and HHS have largely stayed quiet about potential nominees, some names have surfaced in media reports. The Washington Post reported that Dr. Daniel Edney, Mississippi’s state health director, appears on a short list of candidates.
Dr. David Margolius, Cleveland’s director of public health, spoke positively about Edney’s qualifications. Margolius noted that Edney demonstrated thoughtful leadership and genuine dedication to public health improvement during a CDC-led meeting in 2024. According to Margolius, that focus on community health is exactly what the next CDC director must bring to the role.
HHS chief counselor Chris Klomp is leading the formal candidate search. Klomp, formerly the director of Medicare, recently stepped into the counselor role. He is working alongside Secretary Kennedy and the White House team on vetting nominees.
Public Health Experts Sound the Alarm
Growing Criticism Over the Delay
Public health advocates have sharply criticized the administration’s handling of the nomination process. Kayla Hancock, director of the Public Health Project with Protect Our Care, called the missed deadline a sign of “incompetence and neglect.”
Hancock further pointed to the ongoing measles outbreaks across the country as evidence that the CDC urgently needs stable, permanent leadership. “Even as preventable diseases like measles are ravaging communities across the country,” she said, the administration continues to rely on temporary fixes.
Moreover, an anonymous scientist familiar with the situation expressed frustration over how the CDC’s credibility gap is being handled. “They keep saying the CDC has a lot of work to do to earn back the public’s trust,” the scientist noted. “Blaming civil service employees is not the way to fix that.”
Why Permanent CDC Leadership Matters
Stability Is Critical for Public Health
The prolonged leadership vacuum carries real consequences. A permanent, Senate-confirmed CDC director can make binding policy decisions, restore institutional trust, and coordinate a national response to emerging health threats. Acting directors, by contrast, face legal and political limits on their authority.
Currently, measles cases are rising nationally. Additionally, broader concerns about vaccine policy, pandemic preparedness, and the CDC’s scientific credibility remain unresolved. Without a confirmed director, the agency’s ability to act decisively is compromised.
The White House has not provided a timeline for naming a nominee. Until then, the CDC continues to navigate one of its most turbulent periods in recent memory — without the permanent leadership its mission demands.
